Answers are grounded in this paper and cite their sources.
Immunization of monkeys with yellow fever virus-specified nonstructural protein NS1 resulted in protection against fatal hepatitis as well as marked reduction in the magnitude of viremia after subcutaneous challenge with yellow fever virus. The results may be relevant to the design of possible subunit or recombinant flavivirus vaccines.
No takes yet. Share an insight, caveat, or question.
Schlesinger et al. (1986) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: